跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Sofosbuvir and velpatasvir tablets
Approved
化学药品
Sofosbuvir and velpatasvir tablets
GILEAD SCIENCES IRELAND UC
🇨🇳 National Medical Products Administration
Approval Date
Jan 4, 2023
Approval ID
5886a087d8e2a873
Company
GILEAD SCIENCES IRELAND UC
Type
化学药品
Approval Details
Approval Id
5886a087d8e2a873
Approval Number
国药准字HJ20180024
Generic Name
索磷布韦维帕他韦片
Generic Name En
Sofosbuvir and velpatasvir tablets
Trade Name
丙通沙
Brand Name
丙通沙
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含400mg索磷布韦和100mg维帕他韦
Reg Date
2023-01-04
Expired Date
2028-01-03
Company Name
GILEAD SCIENCES IRELAND UC
Production Company Name
GILEAD SCIENCES IRELAND UC
Company Detail Path
/organization/gilead-sciences-ireland-uc
Production Company Detail Path
/organization/gilead-sciences-ireland-uc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 4, 2023
Approval ID
5886a087d8e2a873
Type
化学药品
Back to NMPA Approvals
丙通沙 - NMPA Drug Approval Details